Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
From MaRDI portal
Publication:5122851
DOI10.1002/bimj.200510232zbMath1442.62289OpenAlexW2033969681WikidataQ36593604 ScholiaQ36593604MaRDI QIDQ5122851
Frank Bretz, Willi Maurer, Heinz Schmidli, Amy Racine, Franz König
Publication date: 24 September 2020
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.200510232
multiple testingadaptive testsclosure principlecombination testsadaptive seamless designhypotheses selection
Related Items (5)
SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION ⋮ Seamless phase II/III/IIIb clinical trial designs with different endpoints for different phases ⋮ Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard ⋮ A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity ⋮ Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution
This page was built for publication: Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts